1456693-01-8 Usage
Uses
Used in Organic Synthesis:
(R)-benzyl 2-isopropyl-3-oxo-3,4-dihydropyrazine-1(2H)-carboxylate is used as an intermediate in organic synthesis for the development of various chemical compounds. Its unique structure allows for further functionalization and modification, making it a versatile building block in the creation of new molecules with potential applications in different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (R)-benzyl 2-isopropyl-3-oxo-3,4-dihydropyrazine-1(2H)-carboxylate is used as a key component in the development of new drugs. Its potential pharmacological activities are being investigated for therapeutic applications, particularly in the treatment of various diseases and conditions. (R)-benzyl 2-isopropyl-3-oxo-3,4-dihydropyrazine-1(2H)-carboxylate's structural diversity and the possibility of modifying its functional groups make it a promising candidate for drug discovery and design.
Used in Drug Development:
(R)-benzyl 2-isopropyl-3-oxo-3,4-dihydropyrazine-1(2H)-carboxylate is also utilized in drug development as a starting material or a scaffold for the synthesis of novel pharmaceutical agents. Its unique properties and the ability to fine-tune its structure through chemical modifications make it an attractive option for researchers seeking to create new drugs with improved efficacy, safety, and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 1456693-01-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,5,6,6,9 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1456693-01:
(9*1)+(8*4)+(7*5)+(6*6)+(5*6)+(4*9)+(3*3)+(2*0)+(1*1)=188
188 % 10 = 8
So 1456693-01-8 is a valid CAS Registry Number.
1456693-01-8Relevant academic research and scientific papers
COMPOUNDS FOR USE IN TREATING ACUTE CORONARY SYNDROME AND RELATED CONDITIONS
-
Paragraph 0093; 00231, (2016/05/19)
Provided herein are compounds and pharmaceutically acceptable salts thereof that are useful therapeutics for acute coronary syndrome and related disorders.
LIVER X RECEPTOR MODULATORS
-
Page/Page column 39, (2013/09/26)
Provided herein are novel compounds and pharmaceutically acceptable salts thereof that are liver X receptor modulators. Also provided are compositions comprising compounds of the invention and a carrier. Additionally, use of the compounds herein and methods for treating a disease or disorder associated with the liver X receptor are further described.
LIVER X RECEPTION MODULATORS
-
Page/Page column 52, (2013/09/26)
Provided herein are novel compounds and pharmaceutically acceptable salts thereof that are liver X receptor modulators. Also provided are compositions comprising compounds of the invention and a carrier. Additionally, use of the compounds herein and methods for treating a disease or disorder associated with the liver X receptor are further described.
